Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of modified-release tacrolimus (FK506E/MR4) in transplant recipients
2005-005714-20Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tacrolimus in organ transplant recipient, sponsored by Astellas Pharma. Primary endpoints: Patient survival and Graft survival. Started Apr 2006; status: completed.
02
Drugs
tacrolimus
03
Conditions
organ transplant recipient
Beyond the preview
Go deeper on 2005-005714-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005714-20.